Term
|
Definition
Barbiturate
Treats seizures (epilepsy)
CYP-450 Inducerr |
|
|
Term
|
Definition
Benzodiazepine
Can be used sublingually
Great for the elderly |
|
|
Term
|
Definition
Benzodiazepine
Indicated for sleep
Appropriate for the elderly |
|
|
Term
|
Definition
|
|
Term
|
Definition
High abuse potential
IV/rectal for epilepsy
Benzodiazepine
High doses for skeletal muscle spasms |
|
|
Term
|
Definition
Benzodiazepine
Sedation Dentistry
Anterograde amnesia
Indicated for sleep |
|
|
Term
|
Definition
More potent than valium
Benzodiazepine
Used for restless leg syndrome
Add-on for schizophrenia |
|
|
Term
|
Definition
|
|
Term
|
Definition
C-IV
Used for sleep
Less morning drowsiness |
|
|
Term
|
Definition
C-IV
Used for sleep
No hangover
Expensive |
|
|
Term
|
Definition
Indication: Anxiety
Mid-brain modulator |
|
|
Term
|
Definition
|
|
Term
|
Definition
NRI
Less sedation than other TCAs
Less anti-cholinergic |
|
|
Term
|
Definition
TCA
Most appropriate for elderly d/t less orthostasis |
|
|
Term
| Anafranil (Chlomipramine) |
|
Definition
|
|
Term
| Anafranil (Chlomipramine) |
|
Definition
|
|
Term
|
Definition
Most activating SSRI
Most approprate for depressed obese patients due to its anorexia side effect |
|
|
Term
|
Definition
|
|
Term
|
Definition
TCA
Not sedating or activating
Least GI upset
Not for patients with Alzheimers d/t its anticholinergic effects |
|
|
Term
|
Definition
Less CYP-450 interactions
TCA |
|
|
Term
|
Definition
Antidepressant
Good for patients with CV disease
Warning: males of priapism |
|
|
Term
|
Definition
Indicated for depression
BBW: Hepatotoxicity |
|
|
Term
|
Definition
Alpha-2 antagonist, Increases NE
H1 blockade predominates, causes drowsiness
Stimulates appetite |
|
|
Term
|
Definition
| Indicated for Major Depressive Disorder and Diabetic Neuropathic Pain |
|
|
Term
|
Definition
Blocks dopamine
Potential for seizures at high doses
Used for smoking cessation |
|
|
Term
|
Definition
Typical Antipsychotic
More anticholinergic effect
Blindness at high doses
BBW: Prolongation of QT interval |
|
|
Term
|
Definition
High EPS
Typical Antipsychotic
Most clean
less side effects |
|
|
Term
|
Definition
Atypical Antipsychotic
5HT
Least likely to cause weight gain |
|
|
Term
|
Definition
Atypical Antipsychotic
Most likely to cause weight gain |
|
|
Term
|
Definition
Atypical Antipsychotic
First line for schizophrenia
lowest EPS |
|
|
Term
| Symbyax (Olanzapine-Fluoxetine) |
|
Definition
Zyprexa plus Prozac
Indicated for depressive episodes of bipolar disorder |
|
|
Term
|
Definition
Atypical Antipsychotic
D2 receptors, DA receptors, Serotonin antagonist |
|
|
Term
|
Definition
Anticholinergic
Adjunct in Parkinson's
Controls EPS of Antipsychotics |
|
|
Term
| Lithium Carbonate (Eskalith) |
|
Definition
Indicated for the treatment of bipolar disorder
Interaction with NSAIDs |
|
|
Term
| Sinemet (Carbidopa-Levodopa) |
|
Definition
| Gold standard in Parkinson's Disease |
|
|
Term
|
Definition
Adjunct to sinemet
Used for end of dose wearing off |
|
|
Term
| Stalevo (Carbidopa-Levodopa-Entacapone) |
|
Definition
| Combination of Sinemet and Comtan to reduce cost of drug for the patient |
|
|
Term
Parlodel (Bromocriptine)- Hypoprolactinemia
Mirapex (Pramipexole)- RLS
Requip (Ropinirole) - RLS
Used as first line in the treatment of Parkinson's to avoid early use of Sinemet |
|
Definition
| Dopamine Receptor Agonists and their indications |
|
|
Term
|
Definition
MAOI type B
Adjunct to Sinemet
Stimulant |
|
|
Term
|
Definition
| These types of food should be avoided when using MAOIs |
|
|
Term
|
Definition
MAOI type B
Used for Major Depressive disorder
Caution: Serotonin Syndrome |
|
|
Term
|
Definition
MAOI type B
Used as adjunct to sinemet, or monotherapy
No amphetamine metabolite
Avoid SSRIs, TCAs, St Johns wort |
|
|
Term
|
Definition
Releases DA from the Substantia Nigra
Also used for influenza A
Parkinson's Disease |
|
|
Term
|
Definition
Dopamine agonist
SC injectable
Emetic agent
management of hypomobiltiy Off phenomenon |
|
|
Term
|
Definition
| This is the first ADR seen with Dilantin (Phenytoin) |
|
|
Term
|
Definition
| This is the later adverse effect seen with Dilantin (Phenytoin) |
|
|
Term
|
Definition
Used for epilepsy
Take with food
Interaction with PO calcium
also used for neuropathic pain and diabetic neuropathy |
|
|
Term
|
Definition
IV/IM
Metabolized to phenytoin |
|
|
Term
|
Definition
Anti-convulsant also used for trigeminal neuralgia
BBW: Aplastic anemia and agranulocytosis
CYP-450 Inducer
Monitor for SIADH |
|
|
Term
|
Definition
Control of grand mal, psychomotor, and focal epileptic seizures
Raises seizure threshold
Not DEA Controlled |
|
|
Term
|
Definition
For epilepsy
Main ADR: Somnolence
Avoid Alcohol
OTC and RX interaction: Antacids |
|
|
Term
|
Definition
GABA Analog
Related to Neurontin
CV controlled
Neuropathic pain, Seizures, Post-herpetic neuralgia, Fibromyalgia |
|
|
Term
| Depakene/Depakote (Valproic acid) |
|
Definition
Indicated for Epilepsy, Mania, Migraine prophylaxis
BBW: Hepatotoxicity
Drug interaction: Salicylates
CNS cautions |
|
|
Term
|
Definition
Anticonvulsant
Caution: Steven-Johnsons Syndrome |
|
|
Term
|
Definition
Anticonvulsant
Sulfa Drug
Raises IOP, not for glaucoma pts |
|
|
Term
|
Definition
Cholinesterase inhibitor
Most common drug for Alzheimers |
|
|
Term
|
Definition
Cholinesterase inhibitor
Patch for Alzheimer's Disease |
|
|
Term
|
Definition
For mild-moderate dementia
Enhances cholinergic effects |
|
|
Term
|
Definition
Stimulates
For Alzheimer's Disease
Best if combined with Aricept |
|
|
Term
|
Definition
| This class of drugs should be used to control psychotic symptoms from Parkinson's Disease |
|
|
Term
|
Definition
SNRI
Indicated for Social Anxiety
Warning: Increases BP |
|
|
